1,043
Views
0
CrossRef citations to date
0
Altmetric
Research Article

“Arming half-baked people with weapons!” Information enclaving among professionals and the need for a care-centred model for antibiotic use information in Uganda, Tanzania and Malawi

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & (  and the AMIS, DRUM, HATUA and SNAP Consortia.) ORCID Icon show all
Article: 2322839 | Received 28 Jun 2023, Accepted 21 Feb 2024, Published online: 05 Mar 2024

ABSTRACT

Background

The overuse of antimicrobial medicines is a global health concern, including as a major driver of antimicrobial resistance. In many low- and middle-income countries, a substantial proportion of antibiotics are purchased over-the-counter without a prescription. But while antibiotics are widely available, information on when and how to use them is not.

Objective

We aimed to understand the acceptability among experts and professionals of sharing information on antibiotic use with end users – patients, carers and farmers – in Uganda, Tanzania and Malawi.

Methods

Building on extended periods of fieldwork amongst end-users and antibiotic providers in the three countries, we conducted two workshops in each, with a total of 44 medical and veterinary professionals, policy makers and drug regulators, in December 2021. We carried out extensive documentary and literature reviews to characterise antibiotic information systems in each setting.

Results

Participants reported that the general public had been provided information on medicine use in all three countries by national drug authorities, health care providers and in package inserts. Participants expressed concern over the danger of sharing detailed information on antibiotic use, particularly that end-users are not equipped to determine appropriate use of medicines. Sharing of general instructions to encourage professionally-prescribed practices was preferred.

Conclusions

Without good access to prescribers, the tension between enclaving and sharing of knowledge presents an equity issue. Transitioning to a client care-centred model that begins with the needs of the patient, carer or farmer will require sharing unbiased antibiotic information at the point of care.

Responsible Editor

Maria Emmelin

Background

Increasing use of antimicrobials for humans and animals globally is of great concern because of the growing impact of antimicrobial resistance (AMR) [Citation1–3]. Low- and middle-income countries (LMICs) have been reported to contribute significantly to the increase in antibiotic consumption globally [Citation4,Citation5]. The WHO’s Global Action Plan highlights raising awareness, providing information and improving understanding of AMR as necessary first steps towards making long-term gains against AMR as a global threat [Citation6]. Currently, messaging about AMR focuses on raising awareness of the prevalence and danger of AMR, which can be understood by prescribers and dispensers as a reason to escalate to the use of what they consider to be stronger antibiotics [Citation7,Citation8].

Whilst policies and regulations may be in place to restrict antimicrobial access in many LMICs, antibiotics – one particular group of antimicrobials of current concern for resistance – are often accessed readily over the counter without prescriptions [Citation9–11]. At the same time, information about the use of antibiotics among end users is limited [Citation12,Citation13]. Interventions conducted in Mali, Kenya, Tanzania and England have reported potentially positive impacts of providing medicine use information to end users, suggesting that provision of targeted information through simple strategies such as leaflets can result in the safe use of medicines [Citation14–17]. Yet, this approach remains little used, including in LMICs where formal health care can be patchy. Data tracking the Sustainable Development Goal 3.8.1, access to universal health coverage, suggests 4.5 million people globally remained without access to essential health services in 2021 [Citation18]. Access to veterinary services is known to be very limited in low and middle-income countries, including many African settings [Citation19]. Our study aimed to assess the acceptability and feasibility of sharing information about best practice in how to use antibiotics for residents and farmers in Uganda, Tanzania, and Malawi where increases in antibiotic use are being reported but there is limited access to antibiotic use information.

Methods

The enabling optimal antimicrobial use in East Africa project

Four Global Challenges Research Fund (GCRF) funded consortia collaborated in this project: the Antimicrobials in Society (AMIS) Project in Uganda, Drivers of Resistance in Uganda and Malawi (DRUM), Holistic Approach to Unravel Antibacterial Resistance in East Africa (HATUA) in Uganda, Tanzania and Kenya and Supporting the National Action Plan for Antimicrobial Resistance (SNAP-AMR) in Tanzania. Each project had undertaken research on AMR from a One Health perspective, including antimicrobial use (AMU) practices. To draw together findings on AMR and AMU across an East African context, uncover synergies that could be useful for optimising antibiotic usage (ABU), and avoid separate projects contributing to conflicting messaging throughout the region, a research cluster consisting of the four GCRF projects was formed. An emerging concern from across the consortia was the paucity of information available to end users of antibiotics. Across study settings, our teams noted a desire from residents, farmers, and some medicine sellers for more information about antibiotics [Citation20–27]. In particular, respondents wanted to understand what conditions antibiotics can treat, which antibiotics to use and what dose and duration should be given, as well as antibiotic side effects and contraindications.

Under the AMIS, DRUM, HATUA and SNAP-AMR projects, empirical research involving social science studies on antibiotic use were carried out involving different levels of health and food production systems, providing an opportunity to collectively capture a broad picture of antibiotic networks and the presence or absence of information across these networks. summarises our cross-project analysis of (a) the flow of antibiotics and (b) the distribution of endorsed information on antibiotic use. It reflects the low levels of endorsed information among end users.

Figure 1. Antibiotic drug flows, information sources and desire for information.

Diagram developed through reflective workshops involving researchers from AMIS (Uganda), DRUM (Uganda and Malawi), HATUA (Uganda and Tanzania) and SNAP-AMR (Tanzania).
Figure 1. Antibiotic drug flows, information sources and desire for information.

Documentary analysis and literature review

Documentary analysis of AMR National Action Plans, policy documents on antimicrobial use, pharmaceutical regulations and historical material on regulation of antibiotics and the medical and veterinary professions across the three countries was carried out alongside the workshops to contextualise findings. The documentary analysis focused on summarising the AMR National Action Plans in each country, with a specific focus on how these address antimicrobial usage, a description of the history of regulation as well as current regulation of antibiotics and the history of the medical and veterinary professionals in the three countries. In addition, we reviewed anthropological literature on antibiotic information, including the enclaving of medical knowledge – that is the gate-keeping within particular realms not generally accessible, of where medical knowledge sits, and how that works transnationally in global health. We reviewed literature on how biomedicine and veterinary medicine has evolved in Uganda, Tanzania and Malawi and examined studies that focused on the provision of information on medicine use to end users.

Workshops

We conducted workshops with key medical and veterinary professionals, policy makers and drug regulators to understand the factors shaping the flow of antibiotic drug information to end users and identify where interventions could support provision to end users of essential information about antibiotics.

Six three-hour workshops were conducted. In each of the three countries, one workshop discussed antibiotic information in human health and the other animal health. Each workshop was attended by 7 to 10 healthcare professionals, pharmaceutical regulators and policy makers from either human or animal health. These included representatives of the medical and veterinary profession, district health and veterinary officers, drug regulatory bodies, pharmaceutical association, the veterinary association, the AMR Policy Platform and policy makers with an interest in AMR including representatives from the Ministry of Health and Ministry of Agriculture. Ethical approval for the workshops was granted through each of the consortium studies in Uganda, Tanzania and Malawi. shows a breakdown of the total number of stakeholders that attended each workshop. A topic guide developed through an iterative process based on reflective workshops was followed, with the research team opening with an explanation of their observation of a gap between spaces of antibiotic information and spaces of antibiotic usage, sharing the mapping graphic shown in . The participants were then encouraged to discuss this observation and problem-solve ways to address it. Workshops with human health representatives were given copies of the Coartem (Novartis-produced artemether lumefantrine) packaging that uses pictorial images to encourage end users to complete doses, communicating the need to completely kill all parasites over three days. Workshops with animal health representatives were given copies of an example an information leaflet with pictorial images on the diagnosis and treatment of bovine trypanosomiasis which had been provided to cattle farmers in south Mali [Citation14]. These materials were used to stimulate discussion around models that could be acceptable for sharing antibiotic use information with end users in the three countries and if not where the roadblocks might be and how these could be overcome.

Table 1. Stakeholders attending workshops across the three countries.

Data management and analysis

For the documentary analysis, text from the documents and other materials was summarized systematically under pre-defined dimensions anticipated to shape the sharing of information on antibiotic use, which allowed for direct comparisons across topics and countries [Citation28]. The workshop proceedings were analysed through multiple stages: familiarisation with the data by re-listening to audio recordings and reading and checking transcripts; generation of initial codes to develop a coding frame emergent from the data and comparison between different types of participant and countries to understand differences in contributions. The workshop findings were interpreted in light of the documentary analysis, situating the discussions in the context of historical, national and transnational issues, following established mixed methods analytical processes [Citation29]. The emerging analysis was presented and refined at a series of cross-project multi-disciplinary researcher meetings. Coding and analyses were carried out using qualitative data analysis software, NVivo 12 (QSR International).

Patient and public involvement

End users and farmers were engaged in the primary studies that were conducted in Uganda, Tanzania and Malawi through participation in medicine surveys, focus group discussions and participant feedback meetings to share antibiotic use experiences. These dialogues with participants informed the questions and approach taken in the workshops described in this article.

Results

First, we present the findings emerging from the policy documents review of the context regarding access to antibiotics, access to antibiotic use information and regulation of antibiotics across the three countries. Second, we describe the views of our respondents in the workshops regarding the information on antibiotic use that they considered suitable and unsuitable for end users to receive, and the rationales given for this. We share findings on who they considered responsible for giving this information, the suitable channels for sharing information and considerations they discussed in achieving this.

The human and animal health system and workforce in Uganda, Tanzania and Malawi

In this section, we describe the structure of the human and animal health systems in Uganda, Tanzania and Malawi, followed by a description of key features of human () and animal () health professionals in the three countries.

Table 2. Structure of the human health professions in Uganda, Tanzania and Malawi.

Table 3. Structure of animal health professions in Uganda, Tanzania and Malawi.

Uganda

The human health system in Uganda is a mix of public and private health care providers. The public health system in Uganda is multi-layered including Health Centre IIs at parish level, Health Centre IIIs at sub-county level, Health Centre IVs at county level, and higher-level district hospitals, regional referral hospitals and a national referral hospital. The private sector consists of pharmacies, drug shops, private clinics and private hospitals and the private not for profit health care providers [Citation30]. Veterinary services are organized under the central government and the local government. Veterinarians and paraprofessionals employed by the government provide preventive services free of charge. However, when they provide clinical services, these are paid for by farmers. The veterinary sector is predominantly private with animal health services provided by veterinarians and paraprofessionals [Citation31].

Tanzania

The human public health care system in Tanzania is hierarchical, consisting of dispensaries, health centres, district hospitals, regional hospitals and tertiary hospitals at zonal and national levels [Citation32]. Private health care providers in Tanzania include hospitals, health centres, dispensaries, clinics, laboratories, pharmacies, Accredited Drug Dispensing Outlets and maternity homes. Veterinary services in Tanzania are within the Ministry of Livestock and Fisheries Development and have a central component under the Director of Veterinary Services and a regional component under the local authorities [Citation33]. Animal health services in Tanzania are offered by livestock field officers employed by the Tanzanian Ministry of Livestock and Fisheries, paraprofessionals and agrovet shops where veterinary medicines are sold [Citation34]. Most livestock keepers buy drugs to treat their animals from drug shops run by informal paraprofessionals [Citation35].

Malawi

Malawi’s health system is organized at community, primary, secondary and tertiary level linked to each other through an established referral system [Citation36]. At community level, health services are provided by health surveillance assistants, health posts, dispensaries, and maternity clinics. At primary level, health services are provided by health centres and community hospitals. The secondary level of care consists of district hospitals and Christian Health Association of Malawi hospitals of equivalent capacity. The tertiary level consists of central hospitals that provide specialist health services at regional level. Health services in the public sector are free-of-charge while user fees have to be paid by patients for Christian Health services [Citation37]. The private for-profit sector consists of private hospitals, clinics, laboratories and pharmacies. Traditional healers are also prominent. The private not-for-profit sector comprises religious institutions (some of which are integrated into the public provision), non-governmental organisations, statutory corporations and companies. Veterinary Services in Malawi are under the Ministry of Agriculture and are centralized, with no devolved functions [Citation33]. Informal paraprofessionals are important providers of veterinary services.

Unrestricted access to antibiotics amidst scarcity of information on antibiotic use

Expert participants in the workshops across the three countries agreed that antibiotics were widely accessible and yet information on antibiotic use was scarce. Beyond public and private health facilities, end users were recognised to obtain antibiotics from pharmacies and drug shops with and without prescription. Participants across the three countries described the primary sources of information currently provided to the public on use of medicines as being through medicine package inserts, health care providers and media campaigns. However, package inserts were described as excluding many end users who were unable to read and/or understand English or medical jargon. Participants reported that the information on antibiotics that health care providers shared with patients during their encounters was to emphasise the need for patients to complete the doses of medicines prescribed and communicate that some diseases do not require antibiotic treatment. In Uganda, the National Drug Authority (NDA) was using local media to pass on messages to the general public discouraging undesirable practices such as self-prescription of antibiotics while encouraging good practices such as taking antibiotics as instructed by healthcare providers. In Tanzania, the pharmacy council had developed leaflets for the general public on irrational use of medicines and the likely consequences. The quotes below are indicative of the view held by the majority of those at the workshops with regard to the kind of information on antibiotic use that was being shared with the general public.

Now I can go to the technical people, and I give them as much information but when I go to the public there is a limit to what I give and yes, we talk about these antibiotics many a times we don’t talk about specific antibiotics. But I talk about when I give you this medicine, if they tell you ‘take it like this please try and make sure you take it like that because if you don’t do that, this is what may come out of that.’ I will tell them, ‘if you use this antibiotic without getting it prescribed by an authorised person, this is what might … … this is what is going to happen to you.’ So, I will talk about the dangers. I will talk about how to use, how to store and how to dispose. (Human Health professionals Workshop, Uganda)

Yeah, so you have to just provide information that to a layman person it’s going to make sense and also, they need to understand that they are taking an antibiotic, let us say they have a bacterial infection, and they are being given azithromycin, you have to be told, let’s say you have this infection, and we are giving you an antibiotic, ‘what you are taking is an antibiotic. If you don’t follow the dosage, there is resistance.’ (Human Health professionals Workshop, Malawi)

In the veterinary sector, some participants reported that information on antibiotic use for animal treatment was available in medicine packs but was not well understood by most farmers, who they said were typically illiterate. In Tanzania, the Food and Agricultural Organisation had developed treatment guidelines including information for farmers on the management of diseases in poultry. In Uganda, the NDA was sharing information with farmers through electronic and print media with a focus on addressing AMR and encouraging farmers always to seek the services of trained veterinary professionals. Unrestricted access to antibiotics for animal treatment was reported across the three countries. This was happening amidst complex dynamics around veterinarians. In Uganda, veterinarians were described as not empowered enough to implement laws on antibiotic use because of gaps in the existing policies and laws. Participants reported that with many unqualified professionals offering veterinary services in Tanzania, the trained professionals could hardly compete with them in the farming communities.

Gaps in implementation of antibiotic regulation across Uganda, Tanzania and Malawi

Enforcement of antibiotic regulations was described as lacking across the three countries. In Malawi, participants expressed concerns that licenses were being issued to unqualified people. Malawian participants suggested that organisations responsible for handling the regulation of pharmaceuticals were poorly coordinated; for example, the Ministry of Trade issued licenses without consulting the department of Animal Health and Livestock Development or the Poisons and Medicines Regulatory Authority. Further, despite the law stating that clinics should not run dispensaries if they are within a radius of 5 km from a pharmacy, this practice continued. At the time when we held the workshop in Malawi, the quality of veterinary medicines was not being assessed or approved and veterinary medicines were not being registered. Workshop participants expressed concern that with gaps in enforcement of regulations and porous borders, people were at liberty to import any veterinary medicines they wanted without a permit. In Uganda, respondents reported efforts were being made to pursue the enforcement of regulation and that the NDA were working with local authorities to ensure enforcement of regulation and to support supervision and compliance monitoring. It was also reported that in Uganda, the NDA was also withdrawing their license and medicines from pharmacies and drug shops they found run by unqualified people. The NDA officials also reported engaging in efforts to withdraw antibiotics from the public eye as a measure to minimise their demand by the general public. Similarly, in Tanzania participants reported that the Accredited Drug Dispensing Outlets were poorly supervised by the local government and the pharmacy council that over saw them.

Patients and farmers should receive only limited antibiotic information only

At one of the workshops, a veterinary professional expressed his fears around farmers being equipped with detailed information on use of antibiotics:

There is a very big danger with having, arming half-baked people with weapons. Drugs are weapons that can kill and if they are in the hands of half-baked people you are making them be in danger. (Animal Health Professionals workshop, Uganda)

Whilst this respondent’s language was pointed, his core concerns were voiced repeatedly by workshop participants across all three countries. There was a widespread concern that detailed information on use of antibiotics, including the types, doses and the conditions that can be treated with antibiotics, should not be shared with end users. Experts at the workshops consistently felt that both patients and farmers tended to desire more information than they required. They felt it was not the end user’s role to diagnose conditions that they or their animals suffer from. Respondents felt strongly that the end users’ role was to present to the places where qualified expert health providers could make those assessments and provide prescriptions, with information on, what by implication is, a need-to-know basis.

Participants justified this strongly-held belief on the basis that end users were incapable of properly assimilating information on the use of medicines. Some of the reasons that were given against sharing detailed information with end users included that there are many types of antibiotics, with different dosages and uses for different ailments, all of which had the potential to confuse end users. Farmers were described as being incapable of making a differential diagnosis between conditions with similar symptoms or of fulfilling other conditions for determining appropriate treatment. Participants were of the clear opinion that sharing detailed information on antibiotic use could lead farmers and patients to believe that they themselves were health experts. This proposition was often met with incredulity by the expert participants,

Now, are we going to say that our farmers should treat; are farmers to be doctors themselves? Are we going to say so? Are we going to say that? (Moderator: That they are doctors?)

Yes, they should come to be doctors themselves for their animals because if I am saying use this dose, you see, of injectable antibiotics so, that means that you don’t go to a doctor but use this. (Veterinary professional - Animal Health Professionals Workshop, Tanzania)

Experts’ concerns appeared to be two-fold. First, professionals were concerned that sharing detailed information on antibiotic use would likely increase self-medication and disease mismanagement in both humans and animals, both of which could further drive AMR. Second, experts feared the impacts on their professions. Notwithstanding the many vacancies in the public health sector and the extreme dearth of veterinary professionals, respondents were keen to point out that large numbers of trained human and animal health workers graduated from academic institutions every year across the region. Giving farmers and patients detailed information on antibiotic use threatened to undermine the role of trained animal health workers. Interestingly, in Malawi some participants felt that farmers could be trusted with administering medicines that came in powder form but not those that came in injectable form. Other participants in the same workshop contested the competency of farmers to administer powdered antibiotics, suggesting they would likely use the wrong ratios.

End users and farmers must only be given general guidance on use of medicines

Although there was a general reluctance to share information, some participants acknowledged that it was necessary to share information on antibiotic use with end users because the gaps in enforcement, such as those regulating dispensing, mean that farmers and patients regularly access antibiotics without a prescription and therefore without the (often verbal) instructions that health experts suggest they normally give when prescribing. This said, experts across the three countries only slightly modified their primary view by saying that any such information provided to end users should be of a very general nature and focused on how to use medicines;

I think it’s better we go with the general [approach] that tells people how to respect drugs in general because we’ve already hinted at this point, they [antibiotics] are as varied as [anything] … . and even for me the medic, sometimes I have to open and look at the [instructions for a] new antibiotic, so for the community they are just going to be confused. They just have to learn that with medicines, these are the general principles. (Human Health Professionals Workshop, Uganda)

Further discussion during the workshops led to idea-generating sessions on what might be included if more general information about medicines were delivered to end users. Results are listed in . Notably, most of the information that respondents proposed should be shared with end users fell in the category of instructions on appropriate behaviour rather than in the category of explaining why it would be important to adopt certain practices and the likely benefits.

Table 4. General information about medicines that expert respondents believed should be shared with end users.

Detailed antibiotic use information should be shared only with trained human health and veterinary professionals

Aside from the general information that might be given to end users, study participants across the three countries remained committed to the idea that access to detailed antibiotic use information should be kept within the confines of trained professionals, as explained by this veterinary professional,

Having said that, the context in our country what is closest to doing such a thing [sharing detailed antibiotic use information] will not reach the farmer, at worst it is going to work with the community-based animal health workers who have a specific area of jurisdiction and who are assigned specific responsibilities under a trained professional. (Animal Health Professionals workshop, Uganda)

Beyond trained professionals, participants were of the view that this information might be entrusted with community health workers only if they would undergo some training and receive close supervision. Participants suggested that existing community health structures could be used to share the information – including health educators, community health workers, village health committees or teams, Health Surveillance Assistants, Community Health nurses, animal extension workers and assistant veterinary officers. The community health care system as a channel for disseminating messages was described as follows;

Like he said we have a well-structured community health care system where when the information reaches the district health facility that information is dispensed further to the health centres and the assumption is that each and every community at least has a health centre and if they don’t have that I also know that each community has a local village health committee, and these local village health committees work with health surveillance assistants and these report to the DHO. (Human Health Professionals Workshop, Malawi)

In a hospital setting, the prescriber and dispenser were seen as key people responsible for passing on information on the use of medicines to end users. Participants pointed out that messages on antibiotic use could be incorporated into information sharing structures at the health facilities such as during antenatal clinics and family planning visits. Farmer associations and clubs were also suggested as a channel for sharing information on antibiotic use with farmers. Leaders such as religious and political leaders and schools were also suggested as channels for sharing (limited) information on antibiotic use with end users.

Discussion

With increasing concerns about AMR, the focus of communication campaigns over previous decades has been to raise awareness among end users about the dangers of misusing antibiotics, and more recently the dangers of AMR. Despite this, the consumption of antibiotics purchased over-the-counter in LMICs continues to be high [Citation10,Citation44] including for animal use [Citation23,Citation45]. Our previous research observed a gap at the point of antibiotic use of information on recommended use as agreed by medical and veterinary bodies, and a desire by end users to access this detailed information [Citation20–27]. In this study, findings from our workshops with policy makers, drug regulators and health care professionals revealed that the appetite of these regulatory and professional bodies for devolving antibiotic use information to end users was low. This was rationalised by concerns that information on medicine use is too complicated to be understood by lay people, underpinning a rhetoric that information be ‘safeguarded’ within the confines of trained professionals. This meant that information to be shared with end users was considered best formatted in instructive messages, particularly to follow professional advice. We argue that not only is such enclaving of knowledge a common feature of technocratic and professionalised Western medicine but in this context, is also rooted in the post-colonial histories of Uganda, Tanzania and Malawi. By making visible the social position of antibiotic information among health care professionals, this paper demonstrates tensions that must be addressed while a large number of patients and farmers remain without good access to clinical and veterinary professional services. We propose a move towards point-of-care information about antibiotics from unbiased sources through a client care-centred approach.

Locating antibiotic information

Understanding the physical and social location of antibiotic information, and the potential for this to change, revealed professionals and regulators to be positioned between responsibilities to protect the public and responsibilities towards universal health coverage. One way this was navigated was to draw upon established models of lay ignorance; end users would not be in position to fully understand medical information, carry out differential diagnosis and appropriately use medicines, putting themselves and others at risk. Under the auspices of altruistic paternalism, the perpetuation of a lay ignorance model [Citation26,Citation46] promotes the gatekeeping role of medical professionals. The idea that biomedical knowledge should be kept within the confines of trained professionals has been well described as part of the esoteric knowledge which meant that professionals were experts in relation to their clients, and able to maintain control and autonomy [Citation47]. This positioning was compounded with colonial medicine, as observed in East Africa where medical training was undertaken by medical missions and could only be accessed by a special category of the population [Citation48]. Even with their extensive stay in Africa, few of the colonial authorities who held much of the medical knowledge spoke local languages and instead identified local elites familiar with western medicine to act as intermediaries in dispatching certain medical knowledge but not medical practice [Citation49]. While the practice of restricting medical knowledge in part emerged from genuine concerns for safety, it was also a way to enclave medical knowledge and retain power.

Technical language has been observed to be used as a tool for keeping medical knowledge exclusive to medical professionals [Citation50,Citation51] and the use of Latin in medical texts and case reports may on the one hand serve the purpose of standardising communication among medical professionals worldwide [Citation52] but also reinforces the elite enclaving of medical knowledge. This situation is not unique to the Western biomedical tradition; the mystification of healing knowledge has been observed across a variety of healing traditions around the globe [Citation53,Citation54]. Despite a shift in recent decades towards patient-centred care, this study suggests it will continue to be a challenge for health care professionals to agree to non-medically trained people being given detailed information on medicines in these established social domains [Citation55].

However, there is evidence that drug sellers, livestock keepers and informal paraprofessionals can succeed at identifying conditions for which they can administer treatments themselves [Citation56,Citation57]. Pilot interventions conducted in Mali, England, Kenya and Tanzania have reported potentially positive impacts of providing medicine use information to end users, suggesting that provision of targeted information to patients and farmers through simple strategies such as leaflets can result in safe use of medicines [Citation14–17].

Communicating antibiotic information

Our study participants preferred messages to the public that emphasised compliance with professional instructions coupled with information about the negative consequences of non-compliance, including antimicrobial resistance. We observe that a similar compliance-oriented approach is reflected in the awareness strategies of global health actors to counteract AMR [Citation58], which have mobilised apocalyptic narratives that conceptualise antimicrobial ‘misuse’ – among both humans and animals – as a global ‘threat’ leading towards what many have termed a ‘post-antibiotic era’ [Citation59,Citation60]. Awareness campaigns with the general public have demonstrated limited success, despite being core to the strategies being deployed to address AMR [Citation6,Citation61–63].

This mode of messaging can be understood as a ‘doctor-centred’ rather than ‘patient-centred’ model of care [Citation64]. If the needs of patients, carers and farmers seeking care were centred, not only would the use case for antibiotic information be reorientated towards actionable problem-solving, but the needs for the wider care system for both people and animals would be foregrounded. Attempts to share information with end users in biomedical practice have also been achieved through patient-centred care practices [Citation65], although with some limitations emerging from language differences, differences in vocabulary, age, background and familiarity with medical technology [Citation66].

We propose point-of-care information about antibiotics as a client care-centred approach. In line with the WHO ambition to establish ‘effective medicines information systems to provide independent and unbiased medicine information … to the general public’ [Citation67], the source of such information cannot only be the commercially driven pharmaceutical advertising strategies on which many professionals and clients currently rely on. The WHO Essential Medicines List Antibiotic Book, launched in 2022 and aimed at improving antibiotic awareness, is one such source [Citation68] and in in our particular study countries, the African Medicines Authority, ratified in 2021, also presents an opportunity for a coordinated regulation and information approach.

Limitations and future research

Our research focused on three countries in which the authors have carried out long-standing research into antimicrobial medicines across the health systems. While the workshops reported here round-out our analyses by providing high-level perspectives of those with authority in the human and animal health sectors, it is possible that additional research – for example with donors of medicines and with private sector actors – could have expanded our understanding of the phenomenon of antibiotic information flows. Following from the findings and analysis in this paper, future research could focus on the structures that are maintained through the enclaving of knowledge and consider the consequences of potential disruption, alongside designing and evaluating pilots to shift towards a client-centred model of unbiased antibiotic information at the point-of-care.

Author contributions

The co-authors of this paper put in significant work and personal effort in the conceptualisation, preparation, collection, analysis and interpretation of these data. Data collection was led by SN working in collaboration with workshop committee listed above. Analysis was carried out by SN and CC with inputs from the workshop committee and the project point people listed above. The manuscript was drafted by SN and CC in collaboration with all the other authors. All authors approved the final version of the manuscript.

Ethics and consent

Ethical approval for the workshops was granted through each of the primary studies in Uganda, Tanzania and Malawi through the AMIS, DRUM and SNAP studies. Ethical approval for the AMIS study in Uganda was obtained from the School of Biomedical Sciences Research and Ethics Committee, Makerere University College of Health of Sciences (SBSREC REF no.562), the Uganda National Council for Science and Technology (SS 4679) and the London School of Hygiene and Tropical Medicine Ethics Committee (LSHTM Ethics Ref: 15244). Ethical approval for the DRUM Project in Malawi was obtained from the College of Medicine Research Ethics Committee Malawi (COMREC) (P06/182429) and London School of Hygiene and Tropical Medicine Research Ethics Committee (14617). Ethical approval for SNAP-AMR in Tanzania was obtained from the Kilimanjaro Christian Medical University College Ethics Review committee with certificate n. 2408 and the Catholic University Health and Allied Sciences committee with certificate n. CREC/318/2018; National Institute for Medical Research (NIMR), Tanzania, with Reference Number NIMR/HQ/R.8a/Vol.IX/3017; Tanzanian Commission for Science and Technology (Davis, permit n. 2020–617 335-NA-2019-205; Lembo, permit n. 2020-333-NA-2019-205; Laurie, permit n. 2020–618 332-NA-2019-205; Mutua, permit n. 2020-334-NA-2019-205; Nthambi, permit n. 2020–619 336-NA-2019-205; Matthews, permit n. 2019-482-NA-2019-205; and Hilton, permit n. 620 2019-476-NA-2019-205); and College of Medical Veterinary and Life Sciences ethics 621 committee at the University of Glasgow (project application number 200,180,046). In addition, ethical approval for the previous HATUA studies in Uganda, Tanzania and Kenya was obtained from the University of St Andrews, UK (number MD14548, 10/09/19); National Institute for Medical Research, Tanzania (number 2831, updated 26/07/19); CUHAS/BMC Research Ethics and Review Committee (number CREC/266/2018, updated on 02/2019); Mbeya Medical Research and Ethics Committee (number SZEC-2439/R.A/V.1/303030); Kilimanjaro Christian Medical College, Tanzania (number 2293, updated 14/08/19); Uganda National Council for Science and Technology (number HS2406, 18/06/18); Makerere University, Uganda (number 514, 25/04/18); and Kenya Medical Research Institute (04/06/19, Scientific and Ethics Review Committee (SERU) number KEMRI/SERU/CMR/P00112/3865 V.1.2).

Paper context

AMR action plans prioritise raising public awareness of AMR, including to reduce antibiotic use. Our previous research in Uganda, Malawi and Tanzania showed demand amongst patients and farmers for information about using antibiotics. This study’s workshops with members of regulatory and professional bodies in these countries demonstrated low interest in devolving antibiotic information to end-users, under the rhetoric of safeguarding. Without good access to prescribers, the tension between enclaving and sharing of knowledge presents an equity issue.

Acknowledgments

Special thanks go to Thomasina O’Bryne of AMR Responsive Dialogues, Malawi and Happiness Jeremia of SNAP AMR Tanzania for their hard work organising the workshops. We thank Andrew Sentoogo Ssemata for leading the literature review for this project. We would like to thank policy makers, regulators and health care professionals from Uganda, Tanzania and Malawi who took the time to participate in the stakeholder workshops. We are grateful to Faye Moody and the Liverpool School of Tropical Medicine as well as Prof. Moses Kamya and the Infectious Diseases Research Collaboration for their support to this study.

We also thank the wider consortium members for their support and inputs: Levi Kalitsilo, Janelisa Musaya, Tumaini Malenga (DRUM, Malawi), Ann Katahoire Ruhweza (DRUM, Uganda), Allison Littlejohn, Roxanna Pollack and Ruth Zadoks (SNAP-AMR, Tanzania and Blandina Mmbaga (SNAP and HATUA, Tanzania), Sarah Huque, Matthew Holden, Alison Sandeman, John Kiiru, Benon Asiimwe, Stephen Mshana, Stella Neema, Joseph Mwanga, Katherine Keenan, Wilber Sabiiti, Stephen Gillespie, Derek Sloan, Andy Lynch, John Stelling, Alison Elliot (HATUA, Tanzania and Uganda).

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This study was funded by the Liverpool School of Tropical Medicine as part of the Enabling Optimal Antimicrobial Use in East Africa project with support from the EPSRC, Engineering and Physical Sciences Research Council [WD4 RBPS04394]. The previous empirical research that informed this study was funded under the AMIS, DRUM, HATUA and SNAP-AMR projects. The AMIS study was funded under the Antimicrobials In Society (AMIS) grant awarded by the Economic and Social Research Council (ESRC) on behalf of the Antimicrobial Resistance Cross Council Initiative supported by the seven Research Councils UK (RCUK) in partnership with other funders [ES/P008100/1]. The DRUM Project was funded by the AMR Cross-Council Initiative through a grant from the Medical Research Council [MR/S004793/1]. HATUA was funded by the UK Research and Innovation (UKRI) through a grant from the Medical Research Council [MR/S004785/1]. SNAP-AMR was funded by the UK Research and Innovation (UKRI) through a grant from the Medical Research Council [MR/S004815/1].

References

  • World Health Organisation. Antimicrobial resistance (WHO Fact sheet). 2018 [cited 2019 Sep 12]. Available from: http://www.who.int/en/news-room/fact-sheets/detail/antimicrobial-resistance
  • World Health Organization. Food and agriculture organization, world organisation for animal health. WHO, FAO, and OIE unite in the fight against antimicrobial resistance. ( Flyer) 2015 [cited 2019 Sep 12]. Available from: https://www.who.int/foodsafety/areas_work/antimicrobial-resistance/amr_tripartite_flyer.pdf?ua=1
  • World Health Organisation. WHO report on surveillance of antibiotic consumption: 2016–2018 early implementation. 2018. Available from: https://www.who.int/medicines/areas/rational_use/who-amr-amc-report-20181109.pdf?ua=1
  • Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA. 2018;115:E3463–E70.
  • Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14:742–15. doi: 10.1016/S1473-3099(14)70780-7
  • World Health Organization. Global action plan on antimicrobial resistance. Geneva, Switzerland: WHO; 2015.
  • Pearson M, Chandler C. Knowing antimicrobial resistance in practice: a multi-country qualitative study with human and animal healthcare professionals. Global Health Action. 2019;12:1599560. doi: 10.1080/16549716.2019.1599560
  • Nayiga S, Denyer Willis L, Staedke GS, Chandler CIR. Reconciling imperatives: clinical guidelines, antibiotic prescribing and the enactment of good care in lower-level health facilities in Tororo, Uganda. Glob Public Health. 2022;17:1–12. doi: 10.1080/17441692.2022.2045619
  • Musoke D, Namata C, Lubega GB, Kitutu FE, Mugisha L, Amir S, et al. Access, use and disposal of antimicrobials among humans and animals in Wakiso district, Uganda: a qualitative study. J Pharm Policy Pract. 2021;14:1–12.
  • Do NTT, Vu HTL, Nguyen CTK, Punpuing S, Khan WA, Gyapong M, et al. Community-based antibiotic access and use in six low-income and middle-income countries: a mixed-method approach. Lancet Glob Health. 2021;9:E610–E9.
  • Ndaki PM, Mushi MF, Mwanga JR, Konje ET, Ntinginya NE, Mmbaga BT, et al. Dispensing antibiotics without prescription at community pharmacies and accredited drug dispensing outlets in Tanzania: a cross-sectional study. Antibiotics. 2021;10:1025. doi: 10.3390/antibiotics10081025
  • Gabriel S, Manumbu L, Mkusa O, Kilonzi M, Marealle AI, Mutagonda RF, et al. Knowledge of use of antibiotics among consumers in Tanzania. JAC Antimicrob Resist. 2021;3:dlab183. doi: 10.1093/jacamr/dlab183. Epub 20211130; PubMed PMID: 34859224; PubMed Central PMCID: PMCPMC8634462.
  • Mboya EA, Davies ML, Horumpende PG, Ngocho JS, Lacetera N. Inadequate knowledge on appropriate antibiotics use among clients in the Moshi municipality Northern Tanzania. PLoS One. 2020;15:e0239388. doi: 10.1371/journal.pone.0239388
  • Grace D, Randolph T, Diall O, Clausen P. Training farmers in rational drug-use improves their management of cattle trypanosomosis: a cluster-randomised trial in south Mali. Prev Vet Med. 2008;83:83–97. doi: 10.1016/j.prevetmed.2007.06.005
  • Machila N, Emongor R, Shaw AP, Welburn SC, McDermott J, Maudlin I, et al. A community education intervention to improve bovine trypanosomiasis knowledge and appropriate use of trypanocidal drugs on smallholder farms in Kenya. Agric Syst. 2007;94:261–72. doi: 10.1016/j.agsy.2006.09.004
  • Valimba R, Liana J, Joshi MP, Rutta E, Embrey M, Bundala M, et al. Engaging the private sector to improve antimicrobial use in the community: experience from accredited drug dispensing outlets in Tanzania. J Pharm Policy Pract. 2014;7:11. doi: 10.1186/2052-3211-7-11. Epub 2014/10/10; PubMed PMID: 25298887; PubMed Central PMCID: PMCPMC4177420.
  • Hayes CV, Mahon B, Sides E, Allison R, Lecky DM, McNulty CAM. Empowering patients to self-manage common infections: qualitative study informing the development of an evidence-based patient information leaflet. Antibiotics. 2021;10:1113. doi: 10.3390/antibiotics10091113
  • World Health Organization. Universal health coverage factsheet. 2023 Oct 5. Available from: https://www.who.int/news-room/fact-sheets/detail/universal-health-coverage-(uhc):2023
  • World Organisation for Animal Health (OIE). Strengthening veterinary services through the OIE PVS pathway. The case for engagement and investment. Available from: https://www.woah.org/app/uploads/2021/03/20190513-business-case-v10-ld.pdf:2019
  • MacPherson EE, Reynolds J, Sanudi E, Nkaombe A, Mankhomwa J, Dixon J, et al. Understanding antimicrobial use in subsistence farmers in Chikwawa district Malawi, implications for public awareness campaigns. PLOS Glob Public Health. 2022;2:e0000314.
  • MacPherson EE, Reynolds J, Sanudi E, Nkaombe A, Phiri C, Mankhomwa J, et al. Understanding antimicrobial resistance through the lens of antibiotic vulnerabilities in primary health care in rural Malawi. Glob Public Health. 2022;17:2630–46. doi: 10.1080/17441692.2021.2015615
  • Nayiga S, Denyer Willis L, Staedke SG, Chandler CIR. Taking opportunities, taking medicines: antibiotic use in rural Eastern Uganda. Med Anthropol. 2022;41:418–30. doi: 10.1080/01459740.2022.2047676
  • Mankhomwa J, Tolhurst R, Eunice M’biya E, Chikowe I, Banda P, Mussa J, et al. A qualitative study of antibiotic use practices in intensive small-scale farming in urban and peri-urban Blantyre, Malawi: implications for antimicrobial resistance. Front Vet Sci. 2022;9. doi: 10.3389/fvets.2022.876513
  • Green DL, Keenan K, Fredricks KJ, Huque SI, Mushi MF, Kansiime C, et al. The role of multidimensional poverty in antibiotic misuse: a mixed-methods study of self-medication and non-adherence in Kenya, Tanzania, and Uganda. Lancet Glob Health. 2023;11:e59–e68. doi: 10.1016/S2214-109X(22)00423-5
  • Kayendeke M, Denyer-Willis L, Nayiga S, Nabirye C, Fortané N, Staedke SG, et al. Pharmaceuticalised livelihoods: antibiotics and the rise of ‘Quick farming’ in peri-urban Uganda. J Biosoc Sci. 2023;55:995–1014. doi: 10.1017/S0021932023000019. Epub 2023/02/10.
  • Denyer Willis L, Kayendeke M, Chandler CI. The politics of irrationality. Med Anthropol Q. 2023;37:1–14. doi: 10.1111/maq.12809
  • Keenan K, Fredricks KJ, Al Ahad MA, Neema S, Mwanga JR, Kesby M, et al. Unravelling patient pathways in the context of antibacterial resistance in East Africa. BMC Infect Dis. 2023;23:414. doi: 10.1186/s12879-023-08392-9
  • Dalglish SL, Khalid H, McMahon SA. Document analysis in health policy research: the READ approach. Health Policy Plann. 2020;35:1424–1431. doi: 10.1093/heapol/czaa064
  • Hammersley M, Atkinson P. Ethnography principles in practice. London: Routledge; 2019.
  • Buregyeya E, Rutebemberwa E, LaRussa P, Lal S, Clarke SE, Hansen KS, et al. Comparison of the capacity between public and private health facilities to manage under-five children with febrile illnesses in Uganda. Malaria J. 2017;16:183. doi: 10.1186/s12936-017-1842-8
  • Arvidsson A, Fischer K, Hansen K, Sternberg-Lewerin S, Chenais E. Diverging discourses: animal health challenges and veterinary care in Northern Uganda. Front Vet Sci. 2022;9. doi: 10.3389/fvets.2022.773903
  • Mukasa O, Masanja H, DeSavigny D, Schellenberg J. A cohort study of survival following discharge from hospital in rural Tanzanian children using linked data of admissions with community-based demographic surveillance. Emerg Themes Epidemiol. 2021;18:4. doi: 10.1186/s12982-021-00094-4
  • Luseba D, Rwambo P. Review of the policy, regulatory and administrative framework for delivery oflivestock health products and services in Eastern and Southern Africa. 2015.
  • Caudell MA, Mangesho PE, Mwakapeje ER, Dorado-García A, Kabali E, Price C, et al. Narratives of veterinary drug use in Northern Tanzania and consequences for drug stewardship strategies in low-income and middle-income countries. BMJ Global Health. 2022;7:e006958. doi: 10.1136/bmjgh-2021-006958
  • Frumence G, Mboera LEG, Sindato C, Durrance-Bagale A, Jung A-S, Mshana SE, et al. Practices and challenges of veterinary paraprofessionals in regards to antimicrobial use and resistance in animals in Dar Es Salaam, Tanzania. Antibiotics. 2021;10:733. doi: 10.3390/antibiotics10060733. Epub 2021/07/03; PubMed PMID: 34204437; PubMed Central PMCID: PMCPMC8234030.
  • Abiiro GA, Mbera GB, De Allegri M. Gaps in universal health coverage in Malawi: a qualitative study in rural communities. BMC Health Serv Res. 2014;14:234. doi: 10.1186/1472-6963-14-234
  • Khuluza F, Haefele-Abah C, Thet Wai K. The availability, prices and affordability of essential medicines in Malawi: a cross-sectional study. PLoS One. 2019;14:e0212125. doi: 10.1371/journal.pone.0212125
  • Ministry of Health. Human resources for health strategic plan 2020–2030 - effective health workforce coverage and resilience. Kampala: Ministry of Health; 2021.
  • Sawatsky AP, Parekh N, Muula AS, Bui T. Specialization training in Malawi: a qualitative study on the perspectives of medical students graduating from the University of Malawi College of Medicine. BMC Med Educ. 2014;14:2. doi: 10.1186/1472-6920-14-2
  • Welttierschutz-gesellschaft e.V. VETS UNITED in Uganda. Knowledge that saves lives. 2023.
  • United Republic of Tanzania. The veterinary act Dar es Salaam. Tanzania: Government Printer; 2003.
  • Uganda veterinary association. 2022. Available from: https://ugandavetassociation.org/about-us/#
  • Tanzania veterinary association. 2022. Available from: https://www.tva.or.tz/
  • Torres NF, Chibi B, Kuupiel D, Solomon VP, Mashamba-Thompson TP, Middleton LE. The use of non-prescribed antibiotics; prevalence estimates in low-and-middle-income countries. A systematic review and meta-analysis. Arch Public Health. 2021;79:2. doi: 10.1186/s13690-020-00517-9
  • Nayiga S, Kayendeke M, Nabirye C, Denyer Willis L, Chandler CIR, Staedke SG. Use of antibiotics to treat humans and animals in Uganda: a cross-sectional survey of households and farmers in rural, urban and peri-urban settings. JAC Antimicrob Resist. 2020;2. doi: 10.1093/jacamr/dlaa082
  • van der Geest S. Training shopkeepers and schoolchildren in medicine use: experiments in applied medical anthropology in East Africa. Med Anthropol Q. 1999;13:253–5. doi: 10.1525/maq.1999.13.2.253. Epub 1999/08/10; PubMed PMID: 10440032.
  • Armstrong D. Medicine as a profession: times of change. BMJ. 1990;301:691–3. doi: 10.1136/bmj.301.6754.691. PubMed Central PMCID: PMCPMC1664061.
  • Palanco Lopez P, Chandler CI. Histories of antibiotics: a one health account of the arrival of antimicrobial drugs to Zimbabwe, Malawi and Uganda. Report for the improving human health flagship initiative, agriculture for nutrition and health research programme, CGIAR. London: London School of Hygeine and Tropical Medicine; 2020.
  • Hokkanen M. Medicine, mobility and the empire: nyasaland networks, 1859–1960. In: Thompson AS, editor. Studies in imperialism. Manchester (UK): Manchester University Press; 2017.
  • Pitt MB, Hendrickson MA. Eradicating jargon-oblivion—a proposed classification system of medical jargon. J Gen Intern Med. 2020;35:1861–1864. doi: 10.1007/s11606-019-05526-1
  • Castro CM, Wilson C, Wang F, Schillinger D. Babel babble: physicians’ use of unclarified medical jargon with patients. Am J Health Behav. 2007;31 Suppl 1:S85–95. doi: 10.5555/ajhb.2007.31.supp.S85. PubMed PMID: 17931142.
  • Lysanets YV, Bieliaieva OM. The use of Latin terminology in medical case reports: quantitative, structural, and thematic analysis. J Med Case Rep. 2018;12:45. doi: 10.1186/s13256-018-1562-x
  • Leslie C, Young A. Paths to Asian medical knowledge, in comparative studies of health systems and medical care. Berkeley (CA): University of California Press; 1992.
  • Littlewood R. On knowing and not knowing in the anthropology of medicine. Abingdon: Routledge; 2010.
  • Armstrong D. Clinical autonomy, individual and collective: the problem of changing doctors’ behaviour. Soc Sci Med. 2002;55:1771–7. doi: 10.1016/s0277-9536(01)00309-4
  • Grace D, Randolph T, Affognon H, Dramane D, Diall O, Clausen P. Characterisation and validation of farmers’ knowledge and practice of cattle trypanosomosis management in the cotton zone of West Africa. Acta Tropica. 2009;111:137–43. doi: 10.1016/j.actatropica.2009.03.009
  • Wafula FN, Goodman CA. Are interventions for improving the quality of services provided by specialized drug shops effective in sub-Saharan Africa? A systematic review of the literature. Int J Qual Health Care. 2010;22:316–23. doi: 10.1093/intqhc/mzq022. Epub 2010/05/01; PubMed PMID: 20430823.
  • World Health Organisation. The evolving threat of antimicrobial resistance options for action. 2012.
  • Langdridge D, Davis M, Gozdzielewska L, McParland J, Williams L, Young M, et al. A visual affective analysis of mass media interventions to increase antimicrobial stewardship amongst the public. British J Health Psychol. 2019;24:66–87. doi: 10.1111/bjhp.12339. PubMed Central PMCID: PMCPMC6585774.
  • Nerlich B. “The post-antibiotic apocalypse“ and the “war on superbugs”: catastrophe discourse in microbiology, its rhetorical form and political function. Public Understanding Sci. 2009;18:574–588. doi: 10.1177/0963662507087974
  • Holloway KA, Rosella L, Henry D, Ahmed N. The impact of WHO essential medicines policies on inappropriate use of antibiotics. PLoS One. 2016;11:e0152020. doi: 10.1371/journal.pone.0152020
  • Haynes C, McLeod C. A review of reviews of educational interventions designed to change the public’s knowledge and behaviour in relation to antimicrobial use and antimicrobial resistance that target healthcare professionals and patients 2015. Available from: https://www.nice.org.uk/guidance/ng63/documents/antimicrobial-stewardship-changing-riskrelated-behaviours-in-the-general-population-review-3-protocol2
  • Price L, Gozdzielewska L, Young M, Smith F, MacDonald J, McParland J, et al. Effectiveness of interventions to improve the public’s antimicrobial resistance awareness and behaviours associated with prudent use of antimicrobials: a systematic review. J Antimicrob Chemother. 2018;73:1464–1478. doi: 10.1093/jac/dky076
  • Mead N, Bower P. Patient-centredness: a conceptual framework and review of the empirical literature. Soc Sci Med. 2000;51:1087–110. doi: 10.1016/S0277-9536(00)00098-8. PubMed PMID: 11005395.
  • Louw JM, Marcus TS, Hugo JFM. Patient- or person-centred practice in medicine? - A review of concepts. Afr J Prim Health Care Fam Med. 2017;9:e1–e7. doi: 10.4102/phcfm.v9i1.1455. Epub 20171019; PubMed PMID: 29113447; PubMed Central PMCID: PMCPMC5675925.
  • Kwame A, Petrucka PM. A literature-based study of patient-centered care and communication in nurse-patient interactions: barriers, facilitators, and the way forward. BMC Nurs. 2021;20:158. doi: 10.1186/s12912-021-00684-2
  • The World Health Organisation. Promoting rational use of medicines. 2023.
  • World Health Organisation. The WHO essential medicines list antibiotic book: improving antibiotic awareness. 2021.